The Institute for Translational Research (ITR) is dedicated to advancing precision medicine for brain disorders, including Alzheimer’s disease, Parkinson’s disease, Down syndrome, and dementia with Lewy bodies. Currently, ITR is conducting three studies related to Alzheimer's:
The HABS study provides information and data to researchers upon request. All information on these studies can be found here.
